Research that moves the field.
Our physicians have led or co-authored the trials behind frameless SRS thalamotomy, HyperArc radiosurgery, and 5-fraction breast SBRT. At the Institute, that work continues — and eligible patients can be part of it.
Low-dose radiotherapy for early Alzheimer's disease
Neuroinflammation is increasingly implicated in the progression of Alzheimer's disease. LDRT-MIND investigates whether precisely delivered, ultra-low-dose brain radiotherapy — the same anti-inflammatory mechanism we use in arthritis — can safely reduce that inflammation and slow cognitive decline.
Participants receive comprehensive cognitive and imaging assessment before and after treatment, delivered on the Varian Edge® with HyperSight™ at our Winter Park facility.
Outcomes registry for LDRT in arthritis & spine arthropathy
Every LDRT patient we treat for osteoarthritis or low back & neck pain is invited into a prospective registry tracking pain relief, function, and durability — building the evidence base for a therapy the US has been slow to adopt.
A track record, not a promise
Our medical director served as principal investigator on the phase I/II prospective trial of frameless, virtual-cone SRS thalamotomy for tremor and has co-authored trials spanning breast SBRT, brain metastases, and cardiac radioablation. See the publication record →
Interested in a trial — for yourself or a patient?
Eligibility is determined at consultation. Referring providers can request a records review first.
Winter Park, FL 32789
Fax (321) 972-1132
The Renaissance Institute is a proud member of Privia Medical Group. The best doctors in our community have joined together to form Privia Medical Group (PMG), a multi-specialty, high-performance medical group that puts patients first. Our physicians are united by the mission of providing better, more coordinated care for their patients.
To learn more about Privia Medical Group and find other Privia doctors, please visit our website.